Compounded Tirzepatide vs Compounded Semaglutide

An honest, side-by-side look at two treatment options — so you and your provider can decide what may work best for you.

How Do They Compare?

Compounded Tirzepatide (Dual GIP/GLP-1 receptor agonist for weight management) and Compounded Semaglutide (GLP-1 receptor agonist for weight management) are both options in the weight-management treatment space. Compounded Tirzepatide Compounded tirzepatide is a dual GIP and GLP-1 receptor agonist that may support weight management by targeting two key hormonal pathways involved in appetite regulation and metabolism. Compounded Semaglutide Compounded semaglutide is a GLP-1 receptor agonist that may help regulate appetite and support weight management goals when combined with diet and exercise. Your provider can help determine which treatment, if any, may be appropriate based on your individual health profile and goals.

All medications referenced on this page are compounded by a licensed 503A pharmacy and are not FDA-approved.

Side-by-Side Comparison

Compounded Tirzepatide

Available Now
$285/mo

If prescribed by a provider

Category

weight-management

Description

Dual GIP/GLP-1 receptor agonist for weight management

Features

  • Targets two hormonal pathways (GIP and GLP-1)
  • May help reduce appetite through dual mechanism
  • Weekly subcutaneous injection
  • Dosage gradually titrated under medical supervision

Considerations

  • Compounded medications are not FDA-approved
  • Common side effects may include nausea, diarrhea, and decreased appetite
  • Not suitable for individuals with a history of MEN 2
  • Requires ongoing provider monitoring

Compounded Semaglutide

Available Now
$285/mo

If prescribed by a provider

Category

weight-management

Description

GLP-1 receptor agonist for weight management

Features

  • May help reduce appetite and food cravings
  • Supports sustainable weight management
  • Weekly subcutaneous injection
  • Dosage gradually increased under provider supervision

Considerations

  • Compounded medications are not FDA-approved
  • Common side effects may include nausea, vomiting, and diarrhea
  • Not suitable for individuals with a history of medullary thyroid carcinoma
  • Requires ongoing medical supervision

Frequently Asked Questions

Compounded tirzepatide is not FDA-approved. All treatments require evaluation and prescription by a licensed healthcare provider. Individual results may vary. This information is not intended to diagnose, treat, cure, or prevent any disease.

Ready to Explore Your Options?

Connect with a licensed provider who can help determine which treatment may be appropriate for your individual health goals.

Get Started

Ready to get started?

Talk to a licensed provider

Get Started